DMDavid P. Miller

David P. Miller

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David P. Miller has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Impact of Drug Samples on Prescribing to the Uninsured

    by David P. Miller, Richard J. Mansfield, Jonathan B. Woods, James L. Wofford, William P. Moran

    Objective: To determine whether drug samples are associated with physicians prescribing fewer generic, less costly medications. Methods: We conducted a retrospective study at a large university-affiliated internal medicine practice containing over 70 physicians. Using a pharmacy database, we identified all prescriptions written to uninsured or Medicaid patients that belonged to one of four...


    • 1 August 2007
      • Vol. 13  (8) , 473-80

    Controlling prescription drug expenditures: a report of success.

    by David P Miller, Curt D Furberg, Ronald H Small, Franklyn M Millman, Walter T Ambrosius, Julia S Harshbarger, Christopher A Ohl

    To determine whether a multi-interventional program can limit increases in prescription drug expenditures while maintaining utilization of needed medications. Quasi-experimental, pre-post design. The program included formulary changes, quantity limits, and mandatory pill splitting for select drugs implemented in phases. We assessed the short-term effects of each intervention by comparing class-specific drug spending and generic medication use before and after benefit changes. Long-term effects were determined by comparing overall spending with projected spending estimates, and by examining changes in the planwide use of generic medications over time. Effects on medication utilization were assessed by examining members' use of selected classes of chronic medications before and after the policy changes. Over 3 years, the plan and members saved $6.6 million attributed to the interventions. Most of the savings were due to the reclassification of select brand-name drugs to nonpreferred status (estimated annual savings, $941,000), followed by the removal of nonsedating antihistamines from the formulary (annual savings, $565,000), and the introduction of pill splitting (annual savings, $342,000). Limiting quantities of select medications had the smallest impact (annual savings, $135,000). Members' use of generic medications steadily increased from 40% to 57%. Although 17.5% of members stopped using at least 1 class of selected medications, members' total use of chronic medications remained constant. A combination of interventions can successfully manage prescription drug spending while preserving utilization of chronic medications. Additional studies are needed to determine the effect of these cost-control interventions on other health outcomes.


  • Open Access

    The effect of health literacy on knowledge and receipt of colorectal cancer screening: a survey study

    by David P Miller, Caroline D Brownlee, Thomas P McCoy, Michael P Pignone

    An estimated one-half of Americans have limited health literacy skills. Low literacy has been associated with less receipt of preventive services, but its impact on colorectal cancer (CRC) screening is unclear. We sought to determine whether low literacy affects patients' knowledge or receipt of CRC screening.


  • Using a computer to teach patients about fecal occult blood screening

    by David P. Miller, James R. Kimberly, L. Douglas Case, James L. Wofford

    OBJECTIVE: To determine whether a multimedia computer program could effectively teach patients about fecal occult blood testing (FOBT) and increase screening rates. DESIGN: Randomized trial. SETTING:...